Core Viewpoint - The IPO of Zhuozheng Medical (02677) has received an enthusiastic market response, with oversubscription exceeding 2,700 times, indicating strong investor interest in the health service consumption sector [1] Group 1: IPO Details - Zhuozheng Medical plans to issue 4.75 million shares globally, with 10% allocated for public offering in Hong Kong at a price of HKD 59.9, and is set to list on February 6 [1] - The company has attracted a prestigious lineup of cornerstone investors, including Kingmed Diagnostics, Xiaopeng Motors' chairman He Xiaopeng, and several Tencent-affiliated tech firms [1] Group 2: Business Model and Strategy - Zhuozheng Medical focuses on the health service consumption market, emphasizing "evidence-based medicine and holistic healthcare" as its core philosophy [1] - The company employs a hybrid model of "physical outlets + online services" to provide comprehensive health management for families, aiming for sustainable financial performance [1] - By leveraging AI technology, Zhuozheng Medical seeks to drive high-quality growth and transformative innovation post-IPO [1]
新股消息 | 卓正医疗(02677)孖展超购逾2700倍 何小鹏、金域、腾讯系生态圈企业参投基石
智通财经网·2026-02-05 02:28